Parvovirus B19 infection in pregnancy

被引:77
作者
de Jong, EP
de Haan, TR
Kroes, ACM
Beersmab, MFC
Oepkes, D
Walther, FJ
机构
[1] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, NL-2333 ZA Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Med Microbiol, Clin Microbiol Lab, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands
关键词
parvovirus B19; intrauterine infection; fetal anemia; intrauterine transfusion;
D O I
10.1016/j.jcv.2006.01.004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Parvovirus B19 is a small single-stranded DNA virus and a potent inhibitor of erythropoiesis, Clue to its cytotoxicity to erythroid progenitor cells. Infection with parvovirus B19 during pregnancy can cause several serious complications in the fetus, such as fetal anemia, neurological anomalies, hydrops fetalis, and fetal death. Early diagnosis and treatment of intrauterine parvovirus B19 infection is essential in preventing these fetal complications. Testing maternal serum for IgM antibodies against parvovirus B19 and DNA detection by PCR can confirm maternal infection. If maternal infection has occurred, ultrasound investigation of the fetus and measurement of the peak systolic flow velocity of the middle cerebral artery are sensitive non-invasive procedures to diagnose fetal anemia and hydrops. Intrauterine transfusion is Currently the only effective treatment to alleviate fetal anemia, but if the fetus is (near) term, induction of delivery should be considered. Most maternal infections with parvovirus B19 occur through contact with infected children at home. Individual counseling Of Susceptible pregnant women will reduce unnecessary fetal deaths. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 45 条
  • [41] Risk factors for parvovirus B19 infection in pregnancy
    Valeur-Jensen, AK
    Pedersen, CB
    Westergaard, T
    Jensen, IP
    Lebech, M
    Andersen, PK
    Aaby, P
    Pedersen, BN
    Melbye, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (12): : 1099 - 1105
  • [42] The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment
    van Kamp, IL
    Klumper, FJCM
    Bakkum, RSLA
    Oepkes, D
    Meerman, RH
    Scherjon, SA
    Kanhai, HHH
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 185 (03) : 668 - 673
  • [43] α5β1 integrin as a cellular coreceptor for human parvovirus B19:: Requirement of functional activation of β1 integrin for viral entry
    Weigel-Kelley, KA
    Yoder, MC
    Srivastava, A
    [J]. BLOOD, 2003, 102 (12) : 3927 - 3933
  • [44] Yaegashi N, 1998, J INFECTION, V37, P28, DOI 10.1016/S0163-4453(98)90346-2
  • [45] Mechanisms of disease - Parvovirus B19
    Young, NS
    Brown, KE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (06) : 586 - 597